Drug Information

 



     






Pharmacokinetics

 


Ceftazidime is given only parenterally and it penetrates tissues well.
Renal tubular blocking with probenicid is reduced in renal
insufficiency. Its concentration in the bile is similar to that of
plasma. Its excretion is reduced in renal impairment. It is metabolised
in the liver and gets excreted via the kidneys.

TOP

 




Indication & Dosage

 


SEVERE INFECTIONS: SEPTICAEMIA, BACTERAEMIA, PERITONITIS, MENINGIITS,
INFECTIONS IN IMMUNO-COMPROMISED PATIENTS WITH HAEMATOLOGICAL OR SOLID
MALIGNANCIES: 2g IV every  8-12 hrs. LOWER RESPIRATORY TRACT
INFECTIONS: PNEUMONIA, PLEURISY, LUNG ABSCESS, BRONCHIECTASIS, LUNG
INFECTIONS IN PATIENTS WITH CYSTIC FIBROSIS: 1-2G iv EVERY 8-12 hrs.

SEVERE OTITIS MEDIA, SINUSITIS MASTOIDITIS: 1-2G IV every 8-12 hrs. UTI
SUCH AS PYELONEPHRITIS: 1-2G iv EVERY 8-12 hrs.

SKIN AND SOFT TISSUE INFECTIONS: 1-2g IV every 8-12 hrs. GI TRACT
INFECTIONS: BONE AND JOINT INFECTIONS: 1-2G iv every 8-12 hrs.

NOTE: In acutely ill elderly max daily dose should be 3g per day.
Children and infants: 30-100mg/kg/day in 2-3 divided doses. Neonates:
25-60mg/kg/day in 2 divided doses. In neonatal meningitis upto
150mg/kg/day has been given in divided doses. Renal insufficiency: Dose
modified according to creatinine clearance.

TOP

 




Action

 

Extended spectrum of activity against Gram-negative bacteria
especially pseudomonas. Highly stable to betalactamases. Synergises with
aminoglycosides.

TOP

 



Interactions



Ceftazidime
gives false positive Coombs test and false positive test for urine
sugar.

TOP

 





Adverse
Effect & Precautions




Skin rash, urticaria,
neutropenia, thrombocytopenia, neutropenia, thrombocytopenia, pain at
injection site pseudomembranous colitis, diarrohoea, fever, headache,
dizziness, phlebitis, rise in liver enzymes and blood urea


Precautions to
be taken in acutely ill elderly patients.

Pregnancy: Use with caution

Breast Feeding: Use with caution.

Man: Use with caution.

TOP

 







































Brands available in market



CEFAZID

Biochem
INJ 250mg VIAL 85.00
INJ

500mg


VIAL


150.00
INJ 1g VIAL 280.00
CEFTIDIN

Lyka
INJ 250mg VIAL 69.00
INJ 1g VIAL 275.00
FORTACEF

Troikaa
INJ 250mg VIAL 108.00
INJ 500mg VIAL 186.00
INJ 1g VIAL 290.00
FORTUM

Glaxo
INJ 250mg VIAL 111.00
INJ 500mg VIAL 192.00
INJ 1g VIAL 352.00
ORZID

Orchid
INJ 250ng/ml VIAL 76.65
INJ 1g/ml

VIAL
252.16
TAZID

Alkem
INJ 250mg 1VIAL 97.00
INJ 500mg 1VIAL 184.00
INJ 1g 1VIAL 341.00
ZIDME

Eli Lilly Ranbaxy
INJ 250mg VIAL 92.00
INJ 500mg VIAL 158.00
INJ 1g VIAL 257.00
ZYTAZ

Cadila Healthcare
INJ 250mg VIAL 98.00
INJ 1g VIAL 340.00





TOP

 



                                                                                                    






 

  

 
Drug Information
 

     

Pharmacokinetics
 

Ceftazidime is given only parenterally and it penetrates tissues well. Renal tubular blocking with probenicid is reduced in renal insufficiency. Its concentration in the bile is similar to that of plasma. Its excretion is reduced in renal impairment. It is metabolised in the liver and gets excreted via the kidneys.

TOP
 

Indication & Dosage
 

SEVERE INFECTIONS: SEPTICAEMIA, BACTERAEMIA, PERITONITIS, MENINGIITS, INFECTIONS IN IMMUNO-COMPROMISED PATIENTS WITH HAEMATOLOGICAL OR SOLID MALIGNANCIES: 2g IV every  8-12 hrs. LOWER RESPIRATORY TRACT INFECTIONS: PNEUMONIA, PLEURISY, LUNG ABSCESS, BRONCHIECTASIS, LUNG INFECTIONS IN PATIENTS WITH CYSTIC FIBROSIS: 1-2G iv EVERY 8-12 hrs.
SEVERE OTITIS MEDIA, SINUSITIS MASTOIDITIS: 1-2G IV every 8-12 hrs. UTI SUCH AS PYELONEPHRITIS: 1-2G iv EVERY 8-12 hrs.
SKIN AND SOFT TISSUE INFECTIONS: 1-2g IV every 8-12 hrs. GI TRACT INFECTIONS: BONE AND JOINT INFECTIONS: 1-2G iv every 8-12 hrs.
NOTE: In acutely ill elderly max daily dose should be 3g per day. Children and infants: 30-100mg/kg/day in 2-3 divided doses. Neonates: 25-60mg/kg/day in 2 divided doses. In neonatal meningitis upto 150mg/kg/day has been given in divided doses. Renal insufficiency: Dose modified according to creatinine clearance.

TOP
 

Action
 
Extended spectrum of activity against Gram-negative bacteria especially pseudomonas. Highly stable to betalactamases. Synergises with aminoglycosides.

TOP
 

Interactions

Ceftazidime gives false positive Coombs test and false positive test for urine sugar.

TOP
 

Adverse Effect & Precautions

Skin rash, urticaria, neutropenia, thrombocytopenia, neutropenia, thrombocytopenia, pain at injection site pseudomembranous colitis, diarrohoea, fever, headache, dizziness, phlebitis, rise in liver enzymes and blood urea

Precautions to be taken in acutely ill elderly patients.
Pregnancy: Use with caution
Breast Feeding: Use with caution.
Man: Use with caution.

TOP
 

CEFAZID

Biochem

INJ

250mg

VIAL

85.00

INJ

500mg

VIAL

150.00

INJ

1g

VIAL

280.00

CEFTIDIN

Lyka

INJ

250mg

VIAL

69.00

INJ

1g

VIAL

275.00

FORTACEF

Troikaa

INJ

250mg

VIAL

108.00

INJ

500mg

VIAL

186.00

INJ

1g

VIAL

290.00

FORTUM

Glaxo

INJ

250mg

VIAL

111.00

INJ

500mg

VIAL

192.00

INJ

1g

VIAL

352.00

ORZID

Orchid

INJ

250ng/ml

VIAL

76.65

INJ

1g/ml

VIAL

252.16

TAZID

Alkem

INJ

250mg

1VIAL

97.00

INJ

500mg

1VIAL

184.00

INJ

1g

1VIAL

341.00

ZIDME

Eli Lilly Ranbaxy

INJ

250mg

VIAL

92.00

INJ

500mg

VIAL

158.00

INJ

1g

VIAL

257.00

ZYTAZ

Cadila Healthcare

INJ

250mg

VIAL

98.00

INJ

1g

VIAL

340.00

TOP
 

                                                                                                    

 

By |2022-07-20T16:44:46+00:00July 20, 2022|Uncategorized|Comments Off on Ceftazidime

About the Author: